How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,019 results for

"covid 19" OR "novel coronavirus"

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. COVID-19 (Novel Coronavirus)

COVID-19 (Novel Coronavirus) COVID-19 (Novel Coronavirus) You need to enable JavaScript to run this app. Person Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow. Subscribe Already subscribed? Language English Search Cancel Specialties KeyboardArrowDown 0 COVID-19 (Novel Coronavirus) List MoreVert AddCircleOutline Follow Share Share AddCircleOutline Follow Share Share General Information Description acute respiratory disease caused (...) by a novel coronavirus (SARS-CoV-2) first identified in December 2019 in Wuhan, Hubei Province, China and spreading worldwide ( ) PubMed 32123347 Nature microbiology Nat Microbiol 20200302 SARS-CoV-2 is a member of beta genus coronaviruses closely related to SARS-CoV ( ) common signs of COVID-19 include fever, cough, and shortness of breath ( ) there is no specific antiviral treatment for COVID-19, but supportive care may help to relieve symptoms and should include support of vital organ functions

2020 DynaMed Plus

2. Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings

Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings - Canada.ca Language selection Search Search Canada.ca Search Menu Main Menu You are here: Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings Table of Contents Introduction The Public Health Agency (...) of Canada (the Agency) develops infection prevention and control (IPC) guidelines to provide evidence-based recommendations to complement provincial/territorial public health efforts in monitoring, preventing, and controlling healthcare-associated infections. This is the preliminary edition of IPC guidance on the coronavirus disease (COVID-19) that was first identified in Wuhan, China. The intended use of this document, infection prevention and control for coronavirus disease (COVID-19): interim

2020 CPG Infobase

3. Novel coronavirus (COVID-19) guidance for acute care

Novel coronavirus (COVID-19) guidance for acute care 1 | Pa g e Ministry of Health Novel Coronavirus (COVID-19) Guidance for Acute Care Version 2 – February 1 1, 2020 This guidance document provides basic information only. It is not intended to take the place of medical advice, communicable diseases surveillance protocols, diagnosis or treatment. What you need to know Acute care settings should: 1. Undertake active screening (asking questions) and passive screening (signage) of patients (...) to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV), and COVID-19. A novel coronavirus is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans, likely through bat reservoirs. Several known coronaviruses

2020 CPG Infobase

4. Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community

Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community Interim Guidance: Public Health Management of cases and contacts associated with novel coronavirus (COVID-19) in the community March 10, 2020 CONTEXT The British Columbia Centre for Disease Control (BCCDC) has adapted the interim guidance from the Public Health Agency of Canada (PHAC) for Regional Health Authorities (RHA) for public health management of human illness (...) caused by the novel coronavirus (COVID-19). The strategy outlined in this guidance is aligned with a containment goal (i.e. to reduce opportunities for transmission to contacts in the community) and is based on the assumption that the virus is primarily spread while the case is symptomatic. This guidance is based on current available scientific evidence and expert opinion and is subject to change as new information on the clinical spectrum, transmissibility and epidemiology becomes available

2020 CPG Infobase

5. Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care

Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Health Protection Scotland This document is uncontrolled when printed. Before use check the HPS COVID-19 page to verify this is the current version Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Version 10.4 Publication date 27 March 2020 Health Protection Scotland 1 Version History Version Date Summary of changes V1.0 23/01/20 First (...) equipment 12 11.5. Carpeted flooring and soft furnishings 12 11.6. On leaving the room 13 11.7. Cleaning of communal areas 13 11.8. Attending deaths 13 12. Further information 13 Appendix 1: Contact details for local Health Protection Teams 14 Health Protection Scotland 4 Appendix 2: Putting on and removing Personal Protective Equipment (PPE) 15 Instructional video 16 Health Protection Scotland 5 1. Introduction Novel coronavirus (COVID-19) is a new is a new strain of coronavirus first identified

2020 Covid-19 Ad hoc guidelines

6. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 1

Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 1 MED CHECK April 2020/ Vol.6 No.16 · Page C N o 16 M ED HECK 2 0 2 0 Editorial The Plague (La Peste in French) Urgent Recommendations Five Don'ts to Prevent COVID-19 and Death Editorial The Plague (La Peste in French) Urgent Recommendations Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death 1. Don't use ibuprofen or other NSAIDs 2. Don't use corticosteroids especially in the early phase (...) of Albert Camus (November 7, 1913-January 4, 1960), a novel written in 1947, shortly after the end of World War II. It predicts the status of the current world being swept by the pandemic of the novel coronavirus infection (COVID-19). I read it for the first time when I was in the second grade of junior high school. It's been a long time, but a strange feeling after reading was completely different from other masterpieces I read in those days and has remained in my memory. The second time I read

2020 Med Check - The Informed Prescriber

7. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 2

Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 2 MED CHECK April 2020/ Vol.6 No.17 · Page 17 C N o 17 M ED HECK 2 0 2 0 Editorial Sin of Being Deceived Urgent Recommendations Five Don'ts to Prevent COVID-19 and Death (Part 2) Five Do's to Prevent COVID-19 and Death Editorial Sin of Being Deceived Urgent Recommendations Five Don’ts to prevent COVID-19 and death (Part 2) 3. Don't use Tamiflu and Xofluza 4. Avoid ACE2 enhancers and (hidden) immunosuppressants 5 (...) season, flu was not very prevalent due to the unusually warm winter. However, a case has been confirmed in which a medical doctor who conducted a rapid testing for a patient suspected influenza was infected with a novel coronavirus (SARS-CoV-2 or COVID-19 virus), because the patient was found infected with SARS-CV-2 later. Therefore, the Japan Medical Association recommended member doctors against testing even in case with suspected flu and recommended diagnosis based on the clinical symptoms [8

2020 Med Check - The Informed Prescriber

8. Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)

Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Abbreviations: ABG, arterial blood gases; CDC, Centers for Disease Control and Prevention; HIV, human immunodeficiency virus. Healthcare providers should immediately notify their local or state health department in the event of a PUI for COVID-19 and should contact and consult with their local and/or state health department for recommendations on testing PUIs for COVID-19. Outpatient (...) Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Unlike influenza and other respiratory illnesses, based on a limited number of confirmed COVID-19 cases, pregnant women do not appear to be at increased risk for severe disease. However, given the lack of data and experience with other coronaviruses such as SARS-CoV and MERS-CoV, diligence in evaluating and treating pregnant women is warranted. This algorithm is designed to aid practitioners in promptly

2020 American College of Obstetricians and Gynecologists

9. Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19)

Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) | Australian Government Department of Health Sub menu Search Menu Search Close You are here Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) The Australian Health Sector Emergency Response Plan for Novel Coronavirus (the COVID-19 Plan) guides the Australian health sector response. Listen Print Share (...) Loading... Downloads Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, . Publication date: 18 February 2020 Publication type: Strategy or framework Intended audience: General public Description: The Australian Health Sector Emergency Response Plan for Novel Coronavirus (the COVID-19 Plan) includes: an overview of the national approach

2020 Queensland Health

10. Novel Coronavirus 2019 (COVID-19)

Novel Coronavirus 2019 (COVID-19) Novel Coronavirus 2019 (COVID-19) | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Novel Coronavirus 2019 (COVID-19) Practice Advisory March 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . The Centers for Disease Control and Prevention (CDC) has released and guidance for . Travel Due to the current risk of COVID-19, CDC (...) women. For more information on seasonal influenza and recommendations for pregnant women see the and . The American College of Obstetricians and Gynecologists will continue to closely monitor the evolution of the 2019 novel coronavirus (COVID-19) in collaboration with the CDC. New and updated information will be shared as it becomes available. This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health

2020 American College of Obstetricians and Gynecologists

11. Novel Coronavirus (COVID-19) Management In Malaysia

Novel Coronavirus (COVID-19) Management In Malaysia Portal Rasmi Kementerian Kesihatan Malaysia Selamat Datang Ke Portal Rasmi Kementerian Kesihatan Malaysia Broadcast Pengenalan Kami Berita Soalan Lazim Pekeliling Hubungi Kami | | | Bahasa Melayu | | | | COVID-19 (Garis Panduan) Maklumat Terkini Garis Panduan Pusat Media Infografik Video Tanya Doktor GARIS PANDUAN 1. Guidelines 2019 Novel Coronavirus (COVID-19) Management In Malaysia No. 4/2020 Nama Dokumen Download Table of Content Annex 1 (...) Sampel Di Luar Waktu Pejabat, Hujung Minggu Dan Cuti Umum Annex 5a : Guidelines on Laboratory Testing For Novel Coronavirus For Patients Under Inevestigation Annex 5b : Laboratory Testing For Inpatient Annex 5c: Triple Layer Packaging Annex 6a: Health Alert Card Annex 6b: Mental Health Alert Card Annex 7: Notification Form Annex 8 : The Infection Prevention And Control (IPC) Measures Annex 9 : Management Of COVID-19 At Point Of Entry Appendix 1 : Passenger Locator Form (as per WHO/ICAO) Appendix 2

2019 Ministry of Health, Malaysia

12. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. Full Text available with Trip Pro

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. There is currently a lack of pathologic data on the novel coronavirus (severe acute respiratory syndrome coronavirus 2) pneumonia, or coronavirus disease 2019 (COVID-19), from autopsy or biopsy. Two patients who recently underwent lung lobectomies for adenocarcinoma were retrospectively found to have had COVID-19 at the time of the operation. These two cases thus provide important (...) first opportunities to study the pathology of COVID-19. Pathologic examinations revealed that apart from the tumors, the lungs of both patients exhibited edema, proteinaceous exudate, focal reactive hyperplasia of pneumocytes with patchy inflammatory cellular infiltration, and multinucleated giant cells. Hyaline membranes were not prominent. Because both patients did not exhibit symptoms of pneumonia at the time of operation, these changes likely represent an early phase of the lung pathology

2020 Journal of Thoracic Oncology

13. Imaging features and mechanisms of novel coronavirus pneumonia (COVID-19): Study Protocol Clinical Trial (SPIRIT Compliant). Full Text available with Trip Pro

Imaging features and mechanisms of novel coronavirus pneumonia (COVID-19): Study Protocol Clinical Trial (SPIRIT Compliant). A novel coronavirus, tentatively designated as 2019 Novel Coronavirus (2019-nCoV), now called severe acute respiratory syndrome coronavirus 2, emerged in Wuhan, China, at the end of 2019 and which continues to expand. On February 11, 2020, the World Health Organization (WHO) named the disease coronavirus disease 2019 (COVID-19). On February 28, WHO increased our (...) assessment of the risk of spread and the risk of impact of COVID-19 to very high at a global level. The COVID-19 poses significant threats to international health.Computed tomography (CT) has been an important imaging modality in assisting in the diagnosis and management of patients withCOVID-19. Some retrospective imaging studies have reported chest CT findings of COVID-19 in the past 2 months, suggesting that several CT findings may be characteristic. To our knowledge, there has been no prospective

2020 Medicine

14. Novel coronavirus 2019 (COVID-19): A case report and review of treatments. Full Text available with Trip Pro

Novel coronavirus 2019 (COVID-19): A case report and review of treatments. Novel coronavirus 2019 (COVID-19) also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, non-segmented positive-sense RNA virus belonging to the beta-coronaviridae family. This virus is known to cause severe bilateral pneumonia and acute respiratory distress syndrome (ARDS) which can lead to difficulty breathing requiring mechanical ventilation and intensive care unit management.A 77 (...) -year-old female with a history of hypertension and hyperlipidemia who presented as a transfer to our hospital facility with worsening fevers, cough, and respiratory distress.Chest X-rays revealed bilateral infiltrates worse at the lung bases and CT scan of the chest showed bilateral ground-glass opacities consistent with COVID-19. While our testing revealed a negative COVID-19 result at our institution, the result at a previous hospital returned a positive result.She was being treated aggressively

2020 Medicine

15. The computation of case fatality rate for novel coronavirus (COVID-19) based on Bayes theorem: An observational study. Full Text available with Trip Pro

The computation of case fatality rate for novel coronavirus (COVID-19) based on Bayes theorem: An observational study. When a new disease such starts to spread, the commonly asked questions are how deadly is it? and how many people are likely to die of this outbreak? The World Health Organization (WHO) announced in a press conference on January 29, 2020 that the death rate of COVID-19 was 2% on the case fatality rate (CFR). It was underestimated assuming no lag days from symptom onset to deaths (...) while many CFR formulas have been proposed, the estimation on Bays theorem is worthy of interpretation. Hence, it is hypothesized that the over-loaded burdens of treating patients and capacities to contain the outbreak (LSBHRS) may increase the CFR.We downloaded COVID-19 outbreak numbers from January 21 to February 14, 2020, in countries/regions on a daily basis from Github that contains information on confirmed cases in >30 Chinese locations and other countries/regions. The pros and cons were

2020 Medicine

16. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China. Full Text available with Trip Pro

The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China. There is currently a global outbreak of coronavirus disease 2019 (COVID-19), and its epidemic characteristics in the areas where the outbreak has been successfully controlled are rarely reported.Describe the epidemic characteristics of COVID-19 in Jingmen, Hubei, introduce the local prevention and control experience, and observe the impact of various prevention and control measures (...) on the number of new cases.All the COVID-19 patients diagnosed in the municipal districts of Jingmen from January 12 to February 29, 2020 were enrolled in this study. We described epidemiological data and observed the impact of control measures on the epidemic.Of the 219 cases (110 men and 109 women), 88 (40%) had exposure to Wuhan. The median age was 48 years (range, 2-88 years; IQR, 35-60). Thirty-three severe patients with a median age of 66 years (range, 33-82 years, IQR, 57-76) were treated

2020 Medicine

17. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. Full Text available with Trip Pro

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. Little is known about COVID-19 outside Hubei. The aim of this paper was to describe the clinical characteristics and imaging manifestations of hospitalized patients with confirmed COVID-19 infection in Wenzhou, Zhejiang, China.In this retrospective cohort study, 149 RT-PCR confirmed positive patients were consecutively enrolled from January (...) of multifocal peripheral ground glass or mixed opacity with predominance in the lower lung is highly suspicious of COVID-19 in the first week of disease onset. Nevetheless, some patients can present with a normal chest finding despite testing positive for COVID-19.We did not receive any fundings.Copyright © 2020. Published by Elsevier Ltd.

2020 Journal of Infection

18. Online Information Exchange and Anxiety Spread in the Early Stage of the Novel Coronavirus (COVID-19) Outbreak in South Korea: Structural Topic Model and Network Analysis. Full Text available with Trip Pro

Online Information Exchange and Anxiety Spread in the Early Stage of the Novel Coronavirus (COVID-19) Outbreak in South Korea: Structural Topic Model and Network Analysis. In case of a population-wide infectious disease outbreak, such as the novel coronavirus disease (COVID-19), people's online activities could significantly affect public concerns and health behaviors due to difficulty in accessing credible information from reliable sources, which in turn causes people to seek necessary (...) information on the web. Therefore, measuring and analyzing online health communication and public sentiment is essential for establishing effective and efficient disease control policies, especially in the early stage of an outbreak.This study aimed to investigate the trends of online health communication, analyze the focus of people's anxiety in the early stages of COVID-19, and evaluate the appropriateness of online information.We collected 13,148 questions and 29,040 answers related to COVID-19 from

2020 Journal of medical Internet research

19. Creating COVID-19 Stigma by Referencing the Novel Coronavirus as the "Chinese virus" on Twitter: Quantitative Analysis of Social Media Data. Full Text available with Trip Pro

Creating COVID-19 Stigma by Referencing the Novel Coronavirus as the "Chinese virus" on Twitter: Quantitative Analysis of Social Media Data. Stigma is the deleterious, structural force that devalues members of groups that hold undesirable characteristics. Since stigma is created and reinforced by society-through in-person and online social interactions-referencing the novel coronavirus as the "Chinese virus" or "China virus" has the potential to create and perpetuate stigma.The aim (...) (postperiod). We used Stata 16 (StataCorp) for quantitative analysis, and Python (Python Software Foundation) to plot a state-level heat map.A total of 16,535 "Chinese virus" or "China virus" tweets were identified in the preperiod, and 177,327 tweets were identified in the postperiod, illustrating a nearly ten-fold increase at the national level. All 50 states witnessed an increase in the number of tweets exclusively mentioning "Chinese virus" or "China virus" instead of coronavirus disease (COVID-19

2020 Journal of medical Internet research

20. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) POSITION ARTICLE AND GUIDELINE Open Access A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Ying-Hui Jin 1 , Lin Cai 2 , Zhen-Shun Cheng 3 , Hong Cheng 4 , Tong Deng 1,5 , Yi-Pin Fan 6,7 , Cheng Fang 1 , Di Huang 1 , Lu-Qi Huang 6,7 , Qiao Huang 1 , Yong Han 2 ,BoHu 8 , Fen Hu 8 (...) 1,18* , Yong-Yan Wang 6,7* , Xing-Huan Wang 1,2* , for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM) Abstract In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named “2019 novel coronavirus (2019-nCoV)” by the World Health Organization (WHO) on 12 January 2020. For it is a never been

2020 Covid-19 Ad hoc guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>